Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 1.04 B1.08 B1.29 B1.11 B1.1 B 4.58 B Research & development ————— — Operating income 672 M678 M511 M634 M793 M 2.62 B Non-Operating Income, Total -15 M-17 M-19 M-14 M-18 M -68 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses -21 M-20 M-20 M-20 M-21 M -81 M Unusual income/expense 6 M3 M1 M6 M3 M 13 M Pretax income 657 M661 M492 M620 M775 M 2.55 B Equity in earnings ————— — Taxes 157 M153 M171 M141 M194 M 659 M Non-controlling/minority interest 21 M26 M27 M28 M26 M 107 M After tax other income/expense ————— — Net income before discontinued operations 479 M482 M294 M451 M555 M 1.78 B Discontinued operations ————— — Net income 479 M482 M294 M451 M555 M 1.78 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 479 M482 M294 M451 M555 M 1.78 B Basic earnings per share (Basic EPS) 9.889.996.139.4711.67 37.26 Diluted earnings per share (Diluted EPS) 9.869.976.129.4511.65 37.19 Average basic shares outstanding 48.2 M48 M47.8 M47.9 M47.3 M — Diluted shares outstanding 48.3 M48.1 M47.9 M48 M47.4 M — EBITDA 704 M672 M503 M650 M784 M 2.61 B EBIT 583 M588 M419 M567 M704 M 2.28 B Cost of revenue 2.6 B2.8 B2.86 B2.68 B2.85 B 11.18 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 79 M84 M84 M83 M80 M 331 M